Medical options for early pregnancy termination

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Newly developed protocols using methotrexate and misoprostol are more than 90 percent effective in terminating pregnancies of less than seven weeks of gestation. Major side effects include cramping and bleeding. In a significant minority of women, the abortion is completed only after a prolonged wait. Nonetheless, abortions completed with methotrexate and misoprostol have been well tolerated and acceptable to patients. Mifepristone (formerly called RU 486) will soon be available in the United States. When used with misoprostol, mifepristone successfully terminates 94 to 99 percent of early pregnancies.

Original languageEnglish (US)
Pages (from-to)533-5378
Number of pages4846
JournalAmerican Family Physician
Volume56
Issue number2
StatePublished - Aug 1997

Fingerprint

Misoprostol
Mifepristone
Methotrexate
Pregnancy
Hemorrhage

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Medical options for early pregnancy termination. / Gold, Marji; Luks, Denise; Anderson, Matthew R.

In: American Family Physician, Vol. 56, No. 2, 08.1997, p. 533-5378.

Research output: Contribution to journalArticle

@article{de1c60e3c4c14d9ba255913013333cfb,
title = "Medical options for early pregnancy termination",
abstract = "Newly developed protocols using methotrexate and misoprostol are more than 90 percent effective in terminating pregnancies of less than seven weeks of gestation. Major side effects include cramping and bleeding. In a significant minority of women, the abortion is completed only after a prolonged wait. Nonetheless, abortions completed with methotrexate and misoprostol have been well tolerated and acceptable to patients. Mifepristone (formerly called RU 486) will soon be available in the United States. When used with misoprostol, mifepristone successfully terminates 94 to 99 percent of early pregnancies.",
author = "Marji Gold and Denise Luks and Anderson, {Matthew R.}",
year = "1997",
month = "8",
language = "English (US)",
volume = "56",
pages = "533--5378",
journal = "American Family Physician",
issn = "0002-838X",
publisher = "American Academy of Family Physicians",
number = "2",

}

TY - JOUR

T1 - Medical options for early pregnancy termination

AU - Gold, Marji

AU - Luks, Denise

AU - Anderson, Matthew R.

PY - 1997/8

Y1 - 1997/8

N2 - Newly developed protocols using methotrexate and misoprostol are more than 90 percent effective in terminating pregnancies of less than seven weeks of gestation. Major side effects include cramping and bleeding. In a significant minority of women, the abortion is completed only after a prolonged wait. Nonetheless, abortions completed with methotrexate and misoprostol have been well tolerated and acceptable to patients. Mifepristone (formerly called RU 486) will soon be available in the United States. When used with misoprostol, mifepristone successfully terminates 94 to 99 percent of early pregnancies.

AB - Newly developed protocols using methotrexate and misoprostol are more than 90 percent effective in terminating pregnancies of less than seven weeks of gestation. Major side effects include cramping and bleeding. In a significant minority of women, the abortion is completed only after a prolonged wait. Nonetheless, abortions completed with methotrexate and misoprostol have been well tolerated and acceptable to patients. Mifepristone (formerly called RU 486) will soon be available in the United States. When used with misoprostol, mifepristone successfully terminates 94 to 99 percent of early pregnancies.

UR - http://www.scopus.com/inward/record.url?scp=0030816612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030816612&partnerID=8YFLogxK

M3 - Article

C2 - 9262533

AN - SCOPUS:0030816612

VL - 56

SP - 533

EP - 5378

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 2

ER -